- Global Pharma News & Resources

Measles, Mumps and Rubella (MMR) Vaccines Market Dynamic Revenue 2020, Business Forecast, Global Analysis by Size, Key Trends, Comprehensive Analysis by Top Leader And Industry Forecast by 2026

Global Measles, Mumps & Rubella (MMR) Vaccines Market

Measles, mumps, and rubella are the three common contagious airborne diseases that are caused by certain viruses, which are generally transmitted through sneezing and coughing. Such diseases could potentially lead to serious complications or even death among children. MMR vaccines are sold as attenuated viral vaccines, which are manufactured in a lyophilized formulation that requires reconstitution with water for diluent injection. These vaccines are available in two forms, namely, monovalent and combinational vaccines.

Get Sample PDF Brochure with Impact of COVID19:

Combinational MMR vaccines comprise a mixture of two or more viral strains. The MMR vaccines are administered by subcutaneous injection to children and adults. According to the CDC, two doses of measles, mumps and rubella vaccines are about 97% effective against measles and 88% effective against mumps. Whereas, one dose is about 93% effective against measles, 78% effective against mumps, and 97% effective against rubella. The few MMR vaccines available in the market at present include ProQuad, Attenuvax by Merck Co. Inc.; Varilrix, Priorixtetra, and MMR by GSK; Trimovax by Sanofi Pasteur; and Tresivac by Serum Institute of India.

Global Measles, Mumps & Rubella (MMR) Vaccines Market Taxonomy

By Product Type:

  • Monovalent
  • Combinational
  • Divalent
  • Trivalent
  • Others

By End User:

  • Hospitals
  • Healthcare Centers
  • Others

Exclusive offer!!! Purchase the report at a discounted rate!!!

Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount

Quick Buy – Measles, Mumps and Rubella (MMR) Vaccines Market Research Report:

Global Measles, Mumps & Rubella (MMR) Vaccines Market Insights

Vaccine manufacturers across the globe have been focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines. In spite of several governmental initiatives, measles is a leading cause of death among young children. Therefore, the increasing success rate of vaccination programs depends on the government initiatives taken by each country. Some organizations are striving to reduce the prevalence of these diseases. For instance, GAVI Alliances has undertaken an initiative to provide vaccination in high-risk countries such as Afghanistan, Chad, Ethiopia, the Democratic Republic of the Congo, Nigeria and Pakistan. Similarly, in 2017, the Government of India launches Pan-India Measles-Rubella vaccination campaign, under which children aged from 9 months to 15 years are vaccinated to reduce the incidence of these disease in children. Such initiatives taken by various organizations and governments are anticipated to aid in the global market growth. Furthermore, the development of combinational vaccines could also help reduce costs, as well as the adverse effects of vaccines, by reducing the number of vaccination programs.

The global MMR vaccines market is geographically segregated into North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. According to the Pan-American Health Organization (PAHO), measles and rubella have been eliminated from the U.S.A.; however, preventing further outbreaks is a major challenge. As per a report by the CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), published in 2014, the U.S. recorded 667 number of measles cases from 27 states, which was the highest number of cases since measles elimination was documented in the U.S. in 2000. This implies that the vaccine programs were unsuccessful in preventing the outbreak of the disease.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Key Players & Significant Developments

The major players participating in the global MMR vaccines market are GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India Ltd., among numerous others.

These companies are focusing on launching new vaccines, in order to enhance their share in the market. According to Access to Medicine Foundation index, 2017, vaccine market is dominated by four major players, collectively referred as ‘big four’: GSK, Merck & Co., Inc., Pfizer, and Sanofi. Big four contribute to 80% of the global vaccine revenue. Players vary significantly by portfolio and pipeline size. Three of the four companies have larger pipelines than Merck & Co., Inc. or Pfizer. In March 2107, GSK’s measles, mumps, and rubella vaccine for indication of measles, mumps, and rubella prophylaxis was in phase III trial, which is expected to commercialize in the forecast period of 2017 to 2025. Priorix and Priorix Tetra Measles, mumps and rubella vaccine of GSK are expected to lose their patents in 2019 in the U.S. Some small players such as Daiichi Sankyo and Takeda are focusing on launching vaccines for MMR in regional markets. For instance, Daiichi Sankyo’s VN-0102/JVC-001 is measles, mumps, and rubella vaccine in phase I clinical trials as of May 2016.

However, side effects associated with vaccinations could be a major factor restraining the growth of the measles, mumps, and rubella vaccine market. For instance, in 1998, Japan stopped using trivalent combinational measles, mumps and rubella vaccine due to outbreak of non-viral meningitis and other damaging side effects, which significantly limited the global MMR vaccines market growth.  Moreover, high costs of single-dose vaccines is another restraining factor for the global market growth. Factors such as limited number of vaccines, stringent manufacturing and approval criteria as well as gap between demand and supply during disease outbreak, and special storage and handling leading to high cost of measles, mumps and rubella vaccines are major factors negatively affecting the growth of the global market.

Table of Content

Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report
Section 1: Global Measles, Mumps and Rubella (MMR) Vaccines Industry Overview
Section 2: Global Economic Impact on Measles, Mumps and Rubella (MMR) Vaccines Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Measles, Mumps and Rubella (MMR) Vaccines Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 24-Mar-2021